Licensed Cultivation vs Illicit Market: Policy Impact on Cannabis Production

Executive Summary

Licensed cannabis cultivation programs are proving more effective at reducing illicit market activity than outright prohibition, according to emerging research and policy analysis across legal states. A May 2026 study published in agricultural economics journals found that counties with licensed cultivation operations experienced measurably lower rates of unlicensed growing compared to jurisdictions maintaining cultivation bans. The findings challenge conventional enforcement-first approaches and suggest that regulated market access creates economic incentives that naturally suppress black market activity. As of mid-2026, 24 states have implemented adult-use cannabis programs with varying cultivation licensing frameworks, while federal Schedule III rescheduling discussions under the Drug Enforcement Administration's ongoing review process are forcing policymakers to reconsider the relationship between legal supply chains and illicit production. The licensed-versus-illicit dynamic now represents the central tension in cannabis policy, affecting everything from tax revenue collection to environmental enforcement, with billions in legal market revenue competing against an estimated $20-30 billion annual illicit market that persists even in legal states.

Why This Matters

The competition between licensed cultivation and illicit markets determines whether legalization achieves its core policy objectives. State governments have collectively invested hundreds of millions in regulatory infrastructure, expecting tax revenue, job creation, and reduced criminal justice costs. California alone projected $1 billion annually in cannabis tax revenue when it launched adult-use sales in 2018, yet by 2025 collections remained 40-50% below projections due to illicit market competition. Licensed operators—from small craft cultivators to multi-state operators like Curaleaf and Trulieve—face existential business challenges when competing against untaxed, unregulated producers who avoid compliance costs averaging $200,000-500,000 annually per cultivation facility. For patients and consumers, the stakes involve product safety and access. Licensed cultivation requires testing for pesticides, heavy metals, microbials, and potency under state regulations, while illicit products bypass these safeguards. Public health officials in Colorado and Oregon have documented cases of contaminated illicit cannabis causing hospitalizations. Environmental impacts also diverge sharply: licensed farms in California must comply with water use restrictions and pesticide regulations under the California Department of Food and Agriculture, while illegal grows in national forests have caused documented watershed damage and wildlife poisoning. Law enforcement resources remain constrained by the persistence of large-scale illicit cultivation. The California Department of Fish and Wildlife reported eradicating over 1 million illicit plants in 2025, diverting officers from other duties. Federal agencies including the U.S. Forest Service continue spending tens of millions annually on eradication in states with legal markets, raising questions about resource allocation when legal alternatives exist.

Background and History

The modern tension between licensed and illicit cannabis cultivation emerged from California's 1996 medical marijuana law, Proposition 215, which created legal protection for patients and caregivers but established no licensing framework for commercial production. This regulatory vacuum persisted for two decades, during which California became the nation's largest cannabis producer—almost entirely through unlicensed cultivation. The Emerald Triangle counties of Humboldt, Mendocino, and Trinity developed sophisticated growing operations serving both medical dispensaries and black markets, with estimates suggesting 50,000-100,000 growers operating in legal gray zones by 2015.

Early Medical Programs and the Licensing Gap (1996-2012)

Between 1996 and 2012, medical cannabis programs in California and other early-adopting states operated without comprehensive cultivation licensing. Colorado's Amendment 20 in 2000 and Washington's Initiative 692 in 1998 created similar patient-caregiver models without commercial frameworks. This period established cultivation patterns that would prove difficult to disrupt: networks of growers, distributors, and retailers operating with varying degrees of legal protection but minimal regulatory oversight. The federal government's position under the Controlled Substances Act, 21 U.S.C. § 812, classified cannabis as Schedule I, creating ongoing tension between state tolerance and federal prohibition that discouraged growers from entering formal licensing systems.

Colorado and Washington Launch Adult-Use Licensing (2012-2014)

Colorado's Amendment 64 and Washington's Initiative 502, both passed in November 2012, created the first comprehensive seed-to-sale licensing frameworks for adult-use cultivation. Colorado's system, implemented in January 2014, required cultivators to obtain licenses from the Colorado Marijuana Enforcement Division, install video surveillance, use state-mandated tracking systems (initially BioTrack, later Metrc), and submit to regular inspections. Washington's Liquor and Cannabis Board implemented similar requirements starting in July 2014. These pioneering programs immediately faced illicit market competition. Washington initially licensed only 334 producers, creating supply shortages that kept retail prices high—$25-35 per gram in 2014-2015—while illicit market prices remained at $10-15 per gram. Colorado's more permissive licensing approach created over 1,400 cultivation facilities by 2016, driving wholesale prices down from $4,000 per pound in 2014 to $1,200-1,500 by 2017, which narrowed the price gap with illicit markets but squeezed licensed operator margins.

California's Regulatory Transformation (2015-2018)

California's transition from unregulated medical cultivation to comprehensive licensing under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), effective January 2018, represented the largest attempted formalization of cannabis cultivation in history. The California Department of Food and Agriculture estimated 50,000-69,000 cultivation sites operated in the state in 2017, with only a small fraction entering the licensing process. By January 2020, California had issued approximately 9,000 cultivation licenses, suggesting that 40,000-60,000 operations either ceased or continued operating illicitly. MAUCRSA's requirements proved formidable: cultivators needed local authorization (which many counties refused to provide), compliance with California Environmental Quality Act review, water rights documentation, and fees ranging from $1,000 for small cultivators to $77,000 for large operations. The result was a bifurcated market where licensed operators faced $200,000-500,000 in annual compliance costs while competing against unlicensed growers with near-zero regulatory overhead.

The Illicit Market Adapts (2018-2025)

Rather than disappearing, illicit cultivation evolved in response to state-level legalization. Law enforcement agencies documented several adaptation patterns. In California, large-scale outdoor grows in the Emerald Triangle declined as enforcement intensified, but indoor cultivation in residential and industrial properties increased, particularly in Southern California. The Los Angeles Police Department reported seizing over 400 unlicensed indoor grows in 2024 alone, many operated by organized networks using residential properties. Oklahoma's medical program, which issued over 8,000 cultivation licenses between 2018 and 2022 with minimal barriers to entry, became a documented source of interstate diversion. Federal prosecutors in the Western District of Oklahoma filed dozens of cases between 2020 and 2025 involving licensed Oklahoma grows shipping product to non-legal states, demonstrating how permissive licensing without robust enforcement can enable illicit activity under legal cover.

Federal Rescheduling Discussions (2023-Present)

The Department of Health and Human Services' August 2023 recommendation to reschedule cannabis from Schedule I to Schedule III under 21 U.S.C. § 811 initiated a Drug Enforcement Administration review process that remained ongoing as of May 2026. Schedule III rescheduling would not legalize cannabis federally but would eliminate Internal Revenue Code Section 280E penalties that prevent licensed businesses from deducting ordinary business expenses, currently adding 40-70% to effective tax rates for licensed cultivators. This tax disadvantage has been identified as a primary factor driving price disparities between licensed and illicit markets. The DEA's Notice of Proposed Rulemaking, expected in 2026, will determine whether rescheduling proceeds and under what conditions. Industry advocates argue that 280E relief is essential for licensed markets to achieve price parity with illicit competition, while opponents contend that rescheduling would increase youth access and normalize cannabis use.

Key Players

State Regulatory Agencies

State cannabis control boards determine licensing requirements, enforcement priorities, and market structure, directly shaping the competitive landscape between licensed and illicit cultivation. The California Department of Cannabis Control (formed in 2021 by merging three predecessor agencies) oversees the nation's largest legal market, managing approximately 9,000 cultivation licenses as of 2026. The agency's enforcement division coordinates with local law enforcement on illicit cultivation abatement, conducting over 500 compliance inspections monthly. Colorado's Marijuana Enforcement Division, operating under the Department of Revenue, pioneered many regulatory frameworks now adopted nationwide, including seed-to-sale tracking and mandatory testing. Washington's Liquor and Cannabis Board takes a more restrictive approach, capping total cultivation licenses and using a lottery system for new applicants, creating artificial scarcity that some analysts argue maintains higher prices and illicit market incentives.

Multi-State Operators

Large-scale licensed cultivators including Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs operate cultivation facilities across multiple states, representing billions in invested capital dependent on effective illicit market suppression. These companies have lobbied extensively for enforcement funding and regulatory reforms to reduce compliance costs. Curaleaf operates over 30 cultivation facilities nationwide with combined capacity exceeding 3 million square feet, making it among the largest legal cannabis producers globally. These operators argue that their scale enables quality control and testing infrastructure that illicit producers cannot match, but they require regulatory frameworks that make compliance economically viable.

Craft and Small-Scale Cultivators

Small licensed farms, particularly in California's Emerald Triangle, face acute pressure from both large-scale licensed competitors and illicit operations. The California Growers Association represents approximately 1,000 small cultivators, many of whom transitioned from decades of unregulated growing. These operators argue that high licensing costs and regulatory complexity favor large corporations while pushing traditional growers toward illicit markets. Humboldt County alone issued over 1,200 cultivation permits between 2018 and 2025, but many small farms have since ceased operations, citing inability to compete with either large licensed operators or untaxed illicit growers.

Law Enforcement and Eradication Programs

The Campaign Against Marijuana Planting (CAMP), California's multi-agency eradication program established in 1983, continues operations despite state-level legalization, focusing on unlicensed cultivation on public and private lands. In 2025, CAMP eradicated over 1 million plants and arrested 200 individuals, primarily targeting large-scale operations in national forests and rural areas. Federal agencies including the U.S. Forest Service, Drug Enforcement Administration, and Bureau of Land Management maintain eradication programs in legal states, spending an estimated $50-75 million annually on operations that critics argue are obsolete given state-level legalization.

Research and Policy Organizations

The RAND Corporation's Drug Policy Research Center has published multiple analyses on illicit market persistence, finding that tax rates above 25-30% combined with high regulatory costs create persistent price gaps that sustain illicit markets. The Reason Foundation and Cato Institute have advocated for reduced licensing barriers and lower tax rates to improve licensed market competitiveness. The Marijuana Policy Project and Drug Policy Alliance support legalization but have criticized implementation failures that enable continued illicit activity, arguing for streamlined licensing and equity programs to bring legacy operators into legal markets.

Legal and Regulatory Framework

The legal architecture governing licensed versus illicit cultivation spans federal prohibition, state regulatory systems, and local control ordinances, creating a complex multi-jurisdictional landscape. At the federal level, the Controlled Substances Act, 21 U.S.C. § 801 et seq., maintains cannabis as a controlled substance (currently Schedule I, potentially Schedule III), making all cultivation technically illegal under federal law regardless of state licensing. However, the Rohrabacher-Farr Amendment (renewed annually in appropriations bills since 2014) prohibits the Department of Justice from using federal funds to prevent states from implementing medical cannabis laws, creating de facto federal tolerance for state-licensed operations.

State Licensing Statutes

State adult-use laws establish cultivation licensing frameworks with widely varying requirements. California's Medicinal and Adult-Use Cannabis Regulation and Safety Act (Business and Professions Code § 26000 et seq.) created a tiered licensing system with categories ranging from "specialty cottage" (up to 5,000 square feet canopy) to "medium" (5,001-10,000 square feet) to "large" (10,001-22,000 square feet for outdoor, unlimited for indoor with local approval). Colorado Revised Statutes § 44-10-101 et seq. establishes similar categories with different size thresholds and requires vertical integration for retail operations, meaning retailers must grow at least 70% of their inventory or purchase from licensed cultivators. Michigan's Marihuana Tracking Act (MCL § 333.27101 et seq.) requires all licensees to use the state's tracking system (Metrc) and limits cultivation licenses based on population, creating artificial scarcity. Illinois' Cannabis Regulation and Tax Act (410 ILCS 705) includes social equity provisions granting licensing priority to applicants from communities disproportionately impacted by cannabis prohibition, attempting to transition legacy operators into licensed markets.

Local Control and Licensing Deserts

Most state laws grant local governments authority to prohibit or restrict cannabis businesses, creating "licensing deserts" where cultivation remains entirely illicit due to local bans. In California, approximately 70% of jurisdictions prohibit commercial cannabis activity, forcing cultivators in those areas to either relocate or operate illegally. This patchwork creates enforcement challenges: a cultivator operating in a jurisdiction that prohibits licensing has no legal pathway to enter the regulated market, regardless of willingness to comply with state requirements.

Enforcement and Penalties

Penalties for unlicensed cultivation vary dramatically by state and scale. California Health and Safety Code § 11358 makes unlicensed cultivation of more than six plants a misdemeanor punishable by up to six months in jail and $500 fine, but large-scale commercial cultivation can trigger felony charges under Health and Safety Code § 11358.1, carrying 16 months to three years in state prison. Asset forfeiture laws in most states allow seizure of property, equipment, and proceeds from unlicensed cultivation, creating significant financial risk. Federal prosecution of cultivation in legal states remains possible but rare. The Department of Justice's Cole Memorandum (2013) and later Sessions Memorandum (2018) provided shifting guidance on federal enforcement priorities, but U.S. Attorneys retain discretion to prosecute. Federal cases typically focus on large-scale operations, interstate trafficking, or involvement of organized crime, rather than small-scale unlicensed grows.

State-by-State Breakdown

California

California operates the world's largest legal cannabis market with approximately $5.3 billion in licensed sales in 2025, yet illicit market sales are estimated at $8-10 billion annually, exceeding legal market volume. The state issued approximately 9,000 active cultivation licenses as of May 2026, concentrated in traditional growing regions including Humboldt County (1,200+ licenses), Mendocino County (800+ licenses), and Santa Barbara County (600+ licenses). Cultivation tax rates were reduced in 2025 from $10.08 per ounce of flower to $0 in an effort to improve licensed market competitiveness, but the 15% excise tax and local taxes up to 10% maintain significant price gaps. The Department of Cannabis Control reported seizing over 1 million illicit plants in 2025, indicating persistent large-scale unlicensed cultivation despite extensive licensing availability.

Colorado

Colorado's mature market, operational since 2014, demonstrates the longest-term dynamics between licensed and illicit cultivation. The state maintains approximately 1,400 active cultivation licenses as of 2026, with total canopy space exceeding 10 million square feet. Wholesale prices stabilized at $800-1,200 per pound by 2025, approaching illicit market pricing and reducing black market incentives. Colorado's 15% excise tax and 15% retail tax create a total tax burden of approximately 30%, which research suggests is near the threshold for maintaining licensed market competitiveness. Law enforcement reports declining illicit cultivation within Colorado, though the state remains a documented source of interstate diversion to non-legal states.

Oklahoma

Oklahoma's medical program, launched in 2018, issued over 8,000 cultivation licenses with minimal barriers to entry, creating massive oversupply and documented diversion. The Oklahoma Medical Marijuana Authority issued licenses to applicants with no residency requirement and minimal capital requirements, resulting in wholesale prices collapsing to $400-600 per pound by 2022. Federal prosecutors in the Western District of Oklahoma filed over 50 cases between 2020 and 2025 involving licensed grows shipping product interstate, demonstrating how overly permissive licensing without enforcement enables illicit activity. In 2024, Oklahoma implemented stricter residency requirements and compliance inspections, reducing active licenses to approximately 4,000 by 2026.

Michigan

Michigan's adult-use market, operational since 2019, licensed approximately 1,000 cultivation facilities by 2026, concentrated in metro Detroit and western Michigan. The state's regulatory system requires Metrc tracking and limits licenses based on population, creating moderate scarcity. Wholesale prices ranged from $1,000-1,500 per pound in 2025, competitive with illicit markets. Michigan's 10% excise tax is among the lowest in legal states, improving licensed market price competitiveness. However, unlicensed cultivation persists in rural areas, particularly in the Upper Peninsula, where enforcement resources are limited.

Illinois

Illinois' adult-use program, launched in January 2020, takes a restrictive licensing approach with approximately 100 cultivation licenses issued through 2026, many awarded through a lottery system prioritizing social equity applicants. This artificial scarcity maintained wholesale prices at $2,000-3,000 per pound through 2025, well above illicit market rates of $1,000-1,500 per pound. High retail prices ($60-80 per eighth ounce) and limited geographic access (many counties have no dispensaries) sustain illicit market demand. The state's 25% effective tax rate on retail sales contributes to price disparities.

New York

New York's adult-use program, authorized in 2021 but with retail sales beginning in late 2022, faced significant implementation delays that allowed illicit markets to flourish. The state's Office of Cannabis Management issued approximately 300 cultivation licenses by May 2026, far below demand. Unlicensed dispensaries proliferated in New York City, with estimates suggesting 1,500-2,000 illicit storefronts operating openly as of early 2026, many supplied by unlicensed cultivation. The state's Conditional Adult-Use Retail Dispensary program prioritized social equity applicants but struggled with financing and real estate challenges, slowing licensed market growth and leaving illicit markets largely unchallenged.

Market and Business Implications

The licensed-versus-illicit dynamic determines profitability, investment returns, and industry structure across the cannabis sector. Multi-state operators have invested over $15 billion in cultivation infrastructure, processing facilities, and retail networks, with returns dependent on capturing market share from illicit competitors. Wholesale cannabis prices—the primary revenue source for cultivators—vary dramatically based on local illicit market competition. In mature markets like Colorado and Oregon, wholesale prices of $800-1,200 per pound approach production costs for many licensed operators, creating consolidation pressure as marginal producers exit.

Cost Structure Disparities

Licensed cultivators face compliance costs that illicit operators avoid entirely. A typical mid-size licensed cultivation facility (10,000 square feet) incurs approximately $300,000-500,000 annually in regulatory compliance costs, including licensing fees ($10,000-80,000 depending on state), testing requirements ($50,000-100,000), security and surveillance systems ($30,000-50,000), track-and-trace system fees ($20,000-40,000), and legal/consulting services ($50,000-100,000). Labor costs are higher for licensed operators due to payroll tax obligations and workers' compensation insurance, adding 20-30% to labor expenses compared to illicit operations paying cash wages. Taxation creates the largest cost disparity. Internal Revenue Code Section 280E prohibits cannabis businesses from deducting ordinary business expenses because cannabis remains federally controlled, resulting in effective federal tax rates of 40-70% on licensed cultivators. State excise taxes (10-15% in most states), cultivation taxes (eliminated in California but present historically), and sales taxes (5-10%) add further burden. An illicit cultivator avoids all taxation, creating a 50-80% cost advantage before considering regulatory compliance costs.

Capital Access and Investment

Licensed operators access institutional capital through private equity, venture capital, and public markets (primarily Canadian exchanges), raising billions for facility construction and operations. Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs are publicly traded with market capitalizations ranging from $1-5 billion as of 2026. However, federal prohibition prevents access to traditional banking and U.S. stock exchanges, increasing capital costs. Illicit operators rely on cash financing and reinvested profits, limiting scale but avoiding disclosure and regulatory scrutiny. The capital intensity of licensed cultivation creates barriers to entry that protect established operators but also limit market responsiveness. Building a compliant cultivation facility requires $5-15 million in capital for mid-size operations, with 18-24 month development timelines. This creates supply rigidity that illicit markets exploit—when demand spikes or new markets open, licensed supply cannot respond quickly, allowing illicit operators to capture demand.

Product Differentiation and Branding

Licensed operators increasingly emphasize product quality, testing, and branding to justify price premiums over illicit alternatives. Strains like Wedding Cake, Gelato, and OG Kush are marketed with detailed terpene profiles (myrcene, limonene, caryophyllene content), cannabinoid percentages, and batch-specific testing results. Premium licensed flower retails for $40-60 per eighth ounce, while illicit market flower of comparable quality sells for $20-30 per eighth ounce, creating a persistent price gap. Some licensed operators target consumers willing to pay premiums for safety assurance, organic certification, and sustainable practices. However, research suggests that price-sensitive consumers—estimated at 40-60% of the market—prioritize cost over compliance, sustaining illicit demand regardless of quality differences.

What Experts Say

Policy researchers and industry analysts broadly agree that licensing frameworks must achieve price competitiveness with illicit markets to succeed, but disagree on optimal approaches. Beau Kilmer, co-director of the RAND Drug Policy Research Center, has emphasized that tax rates above 25-30% of retail price create persistent illicit market advantages. According to RAND research published in 2024, California's effective tax rate of 35-45% (combining state and local taxes) maintains a price gap that sustains illicit markets despite extensive licensing availability. Jonathan Caulkins, professor of operations research and public policy at Carnegie Mellon University, has argued that regulatory complexity imposes hidden costs that exceed direct taxation. In testimony before the California Assembly in 2023, Caulkins stated that streamlining licensing processes and reducing compliance burdens would improve licensed market competitiveness more effectively than tax reductions alone. The California Growers Association has consistently argued that small cultivators face disproportionate compliance burdens, with per-unit costs far exceeding those of large operators. According to the association's 2025 economic analysis, cultivators producing under 5,000 square feet of canopy face compliance costs of $80-120 per pound, while large operators achieve $20-30 per pound, creating structural advantages for consolidation. Law enforcement perspectives vary by jurisdiction. The California Police Chiefs Association has supported increased funding for illicit cultivation enforcement, arguing that licensing alone does not eliminate black markets without robust compliance verification. Conversely, the Law Enforcement Action Partnership, a reform-oriented organization of current and former law enforcement officials, has argued that enforcement-focused approaches are ineffective and that reducing regulatory barriers would more effectively transition legacy operators into legal markets. The National Cannabis Industry Association has advocated for federal rescheduling to eliminate 280E tax penalties, arguing this is the single most impactful reform for licensed market competitiveness. According to the association's 2025 economic analysis, 280E relief would reduce licensed operator costs by 15-25%, enabling price reductions that would significantly narrow gaps with illicit markets.

What's Next

The Drug Enforcement Administration's rescheduling decision, expected in late 2026, will fundamentally reshape the competitive landscape between licensed and illicit cultivation. If cannabis is rescheduled to Schedule III, licensed operators would gain immediate relief from Section 280E tax penalties, reducing effective tax rates by 15-25% and enabling significant price reductions. Industry analysts project that 280E relief could reduce retail prices by 10-20%, substantially narrowing the price gap with illicit markets. Several states are implementing or considering reforms to improve licensed market competitiveness. California's 2025 elimination of cultivation taxes removed approximately $100-150 per pound in costs for licensed growers, though impacts on retail prices remain unclear. New York is considering reducing its 13% retail tax to 9% in 2027 legislation, while Illinois is debating whether to increase cultivation licenses beyond the current 100 to improve supply and reduce prices. Enforcement priorities are shifting toward large-scale illicit operations rather than small personal grows. California's Department of Cannabis Control announced in April 2026 that it would focus enforcement resources on operations exceeding 1,000 plants and those involving environmental damage, organized crime, or interstate trafficking, rather than small-scale legacy growers. This approach acknowledges resource constraints and attempts to prioritize the most harmful illicit activity. Technology and tracking systems continue evolving to improve supply chain transparency and reduce diversion. Several states are piloting blockchain-based tracking systems to supplement or replace Metrc, with proponents arguing that distributed ledger technology provides better data integrity and real-time visibility. However, implementation costs and technical complexity remain barriers. The social equity licensing movement is expanding, with over 15 states implementing programs to prioritize applicants from communities disproportionately impacted by prohibition. These programs aim to transition legacy operators into licensed markets while addressing historical injustices, though implementation challenges including access to capital, real estate, and technical expertise have limited success to date. Interstate commerce remains prohibited under federal law, but several states are exploring compacts that would allow licensed product movement across state lines if federal law changes. The Interstate Cannabis Commerce Working Group, formed in 2025 by regulators from Colorado, Oregon, and Washington, is developing model frameworks for interstate licensing recognition and product tracking, preparing for potential federal reform.

Further Reading

• Drug Enforcement Administration, "Schedules of Controlled Substances: Rescheduling of Marijuana" (Notice of Proposed Rulemaking, expected 2026) — https://www.dea.gov
• California Department of Cannabis Control, "Cannabis Licensing" — https://cannabis.ca.gov/applicants/
• RAND Corporation, "Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions" (2015) — https://www.rand.org/pubs/research_reports/RR864.html
• Colorado Department of Revenue, Marijuana Enforcement Division Annual Reports (2014-2025) — https://sbg.colorado.gov/med
• Caulkins, Jonathan P., et al., "Marijuana Legalization: What Everyone Needs to Know" (Oxford University Press, 2nd ed. 2016)
• California Growers Association, "The State of the California Cannabis Market" (2025) — https://www.californiagrowersassociation.org
• U.S. Code, Title 21, Chapter 13 (Drug Abuse Prevention and Control) — https://www.law.cornell.edu/uscode/text/21/chapter-13
• National Conference of State Legislatures, "State Medical Cannabis Laws" — https://www.ncsl.org/health/state-medical-cannabis-laws
• Marijuana Policy Project, "State-by-State Cannabis Policy Reform" — https://www.mpp.org/states/
• California Legislative Analyst's Office, "The California Cannabis Industry: An Overview" (2019) — https://lao.ca.gov/reports/2019/4125/california-cannabis-industry-122019.pdf